Jeremy Grantham's MEDP Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 34.1K shares of Medpace Holdings, Inc. (MEDP) worth $17.53 M, representing 0.05% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in MEDP, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 32.9K shares. Largest reduction occurred in Q4 2024, reducing 21.0K shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Medpace Holdings (MEDP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medpace Holdings (MEDP) Trades by Jeremy Grantham
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2018 | +18,600 | New Buy | 18,600 | $34.89 |
| Q2 2018 | +700 | Add 3.76% | 19,300 | $43.01 |
| Q3 2018 | -6,800 | Reduce 35.23% | 12,500 | $59.92 |
| Q1 2019 | -12,500 | Sold Out | 12,500 | $0.00 |
| Q2 2023 | +45,374 | New Buy | 45,374 | $240.17 |
| Q3 2023 | +8,635 | Add 19.03% | 54,009 | $242.13 |
| Q4 2023 | -2,444 | Reduce 4.53% | 51,565 | $306.53 |
| Q1 2024 | -16,760 | Reduce 32.50% | 34,805 | $404.15 |
| Q2 2024 | +3,432 | Add 9.86% | 38,237 | $411.85 |
| Q3 2024 | -38,237 | Sold Out | 38,237 | $0.00 |
| Q4 2024 | +17,192 | New Buy | 17,192 | $332.23 |
| Q1 2025 | +4,818 | Add 28.02% | 22,010 | $304.69 |
| Q2 2025 | +11,768 | Add 53.47% | 33,778 | $313.86 |
| Q3 2025 | +319 | Add 0.94% | 34,097 | $514.16 |
Jeremy Grantham's Medpace Holdings Investment FAQs
Jeremy Grantham first purchased Medpace Holdings, Inc. (MEDP) in Q1 2018, acquiring 18,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Medpace Holdings, Inc. (MEDP) for 31 quarters since Q1 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's largest addition to Medpace Holdings, Inc. (MEDP) was in Q2 2023, adding 45,374 shares worth $10.9 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 34,097 shares of Medpace Holdings, Inc. (MEDP), valued at approximately $17.53 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Medpace Holdings, Inc. (MEDP) represents approximately 0.05% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's peak holding in Medpace Holdings, Inc. (MEDP) was 54,009 shares, as reported at the end of Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.